Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation
Open Access
- 11 June 2026
- journal article
- Published by Elsevier in eClinicalMedicine
- Vol. 96, 104014
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cancer and fertility management: FIGO best practice adviceInternational Journal of Gynecology & Obstetrics, 2025
- Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTRTransplantation and Cellular Therapy, 2025
- CAR T-cell therapy in autoimmune diseases: where are we and where are we going?The Lancet Rheumatology, 2025
- Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphomaNature Reviews Clinical Oncology, 2025
- The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCTBone Marrow Transplantation, 2025
- CAR T cells in autoimmune disease: On the road to remissionImmunity, 2024
- Current understanding and management of CAR T cell-associated toxicitiesNature Reviews Clinical Oncology, 2024
- CAR T therapies in multiple myeloma: unleashing the futureCancer Gene Therapy, 2024
- Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2023
- Fertility and CAR T-cells: Current practice and future directionsTransplantation and Cellular Therapy, 2022